{"disease":{"id":"x-linked","name":"x linked"},"drugs":{"marketed":[{"drug_id":"burosumab","indication_name":"Familial x-linked hypophosphatemic vitamin D refractory rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Crysvita","generic_name":"BUROSUMAB","company_name":"Ultragenyx Pharm Inc","drug_phase":"marketed","molecular_target":"FGF23","drug_class":"","quality_score":62,"revenue":"700","mechanism":"Burosumab-twza binds to and inhibits FGF23, restoring renal phosphate reabsorption and increasing 1,25 dihydroxy vitamin D levels."},{"drug_id":"ergocalciferol","indication_name":"Familial x-linked hypophosphatemic vitamin D refractory rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Drisdol","generic_name":"ERGOCALCIFEROL","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial","drug_class":"Provitamin D2 Compound [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"calciferol","indication_name":"Familial x-linked hypophosphatemic vitamin D refractory rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Calciferol","company_name":"Department of Medical Services Ministry of Public Health of Thailand","drug_phase":"phase_1","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"burosumab-twza","indication_name":"Familial x-linked hypophosphatemic vitamin D refractory rickets","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"CRYSVITA","generic_name":"BUROSUMAB-TWZA","company_name":"KYOWA KIRIN","drug_phase":"marketed","molecular_target":"Fibroblast growth factor 23","drug_class":"","quality_score":20,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT04157595","title":"Mackenzie's Mission: The Australian Reproductive Carrier Screening Project","phase":"NA","overall_status":"COMPLETED","enrollment_count":18302,"lead_sponsor_name":"Murdoch Childrens Research Institute","has_results":false},{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT05902351","title":"Natural History Study for Charcot Marie Tooth Disease","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Hereditary Neuropathy Foundation","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT00128973","title":"Evaluation of Patients With Immune Function Abnormalities","phase":"","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03193476","title":"Registry for Patients With X-Linked Hypophosphatemia","phase":"","overall_status":"RECRUITING","enrollment_count":1343,"lead_sponsor_name":"Kyowa Kirin Pharmaceutical Development Ltd","has_results":false},{"nct_id":"NCT00001405","title":"Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes","phase":"","overall_status":"RECRUITING","enrollment_count":850,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06523582","title":"Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients","phase":"","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"Universidad Nacional Autonoma de Mexico","has_results":false},{"nct_id":"NCT03179631","title":"Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT03321604","title":"Kidney Information Network for Disease Research and Education","phase":"","overall_status":"TERMINATED","enrollment_count":338,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03584165","title":"Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":330,"lead_sponsor_name":"NightstaRx Ltd, a Biogen Company","has_results":false},{"nct_id":"NCT02699190","title":"LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies","phase":"","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT01826487","title":"Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT03745521","title":"Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":226,"lead_sponsor_name":"Kyowa Kirin Co., Ltd.","has_results":false},{"nct_id":"NCT02090959","title":"An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":219,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT04926129","title":"Natural History of the Progression of X-Linked Retinitis Pigmentosa","phase":"","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"NightstaRx Ltd, a Biogen Company","has_results":false},{"nct_id":"NCT04675749","title":"Quality of Life in Women with X-linked Adrenoleukodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Leipzig University Medical Center","has_results":false},{"nct_id":"NCT05939232","title":"Registry of X-linked Adrenoleukodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT07328178","title":"Analysis of the Role of IgE Proteoforms in Health and Disease","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"KU Leuven","has_results":false},{"nct_id":"NCT06982417","title":"InsightRP2 Registry","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Göttingen","has_results":false},{"nct_id":"NCT02526160","title":"Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":134,"lead_sponsor_name":"Kyowa Kirin, Inc.","has_results":true},{"nct_id":"NCT03862950","title":"A Trial of Metformin in Individuals With Fragile X Syndrome (Met)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT03479476","title":"A Trial of Metformin in Individuals With Fragile X Syndrome","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT07183579","title":"Effective Dosing of Burosumab in XLH","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT04671433","title":"Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT03278899","title":"A Study to Prospectively Assess Disease Progression in Male Children With X-ALD","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"NeuroVia, Inc.","has_results":false},{"nct_id":"NCT05321407","title":"COVID-19 Vaccine Responses in PIDD Subjects","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03820518","title":"Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT04794101","title":"Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":97,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT04273490","title":"Characterising Pain, QoL, Body Composition, Arterial Stiffness, Muscles and Bones in Adult Persons With XLH and Healthy Controls","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04850118","title":"A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":85,"lead_sponsor_name":"Beacon Therapeutics","has_results":false},{"nct_id":"NCT04687007","title":"SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Leipzig University Medical Center","has_results":false},{"nct_id":"NCT06921720","title":"Phosphorus-31 Spectroscopy in Phosphate Diabetes","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":65,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT02915705","title":"Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLH","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Kyowa Kirin, Inc.","has_results":true},{"nct_id":"NCT04872907","title":"Prevention of Spontaneous Dental Abscesses in Children With X-linked Hypophosphatemia : a RCT","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04419363","title":"Burosumab in Children and Adolescents With X-linked Hypophosphatemia","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":57,"lead_sponsor_name":"Bicetre Hospital","has_results":false},{"nct_id":"NCT02163577","title":"Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Kyowa Kirin, Inc.","has_results":true},{"nct_id":"NCT06581146","title":"A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Astellas Gene Therapies","has_results":false},{"nct_id":"NCT04937907","title":"Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Shanghai Children's Hospital","has_results":false},{"nct_id":"NCT03019458","title":"MINGO Supplemental Trial in X-linked Dystonia-Parkinsonism Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Sunshine Care Foundation","has_results":true},{"nct_id":"NCT03116113","title":"A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT03252847","title":"Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"MeiraGTx UK II Ltd","has_results":true},{"nct_id":"NCT04312672","title":"Long-term Follow-up Gene Therapy Study for RPGR- XLRP","phase":"","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT01306019","title":"Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03596554","title":"X-linked Hypophosphatemia and FGF21","phase":"","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT01884311","title":"Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Bio Products Laboratory","has_results":true},{"nct_id":"NCT04695860","title":"Anti-FGF23 (Burosumab) in Adult Patients With XLH","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Wuerzburg University Hospital","has_results":false},{"nct_id":"NCT03879915","title":"Dental Implants in Patients With X-linked Hypophosphatemia","phase":"","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03920072","title":"Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Kyowa Kirin Pharmaceutical Development Ltd","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}